Amplia Therapeutics Ltd
ASX:ATX
Amplia Therapeutics Ltd
ASX:ATX
Price:
0.12
AUD
-4%
Market Cap:
AU$61.6m
Income Statement
Earnings Waterfall
Amplia Therapeutics Ltd
Amplia Therapeutics Ltd
Income Statement
Amplia Therapeutics Ltd
Amplia Therapeutics Ltd
Currency: AUD
| Mar-2016 | Sep-2016 | Mar-2017 | Sep-2017 | Mar-2018 | Sep-2018 | Mar-2019 | Sep-2019 | Mar-2020 | Sep-2020 | Mar-2021 | Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
2
N/A
|
3
+16%
|
2
-31%
|
1
-28%
|
1
-51%
|
0
-94%
|
0
+26%
|
0
N/A
|
0
N/A
|
1
+2 502%
|
2
+72%
|
1
-7%
|
2
+39%
|
3
+49%
|
1
-61%
|
2
+63%
|
4
+137%
|
3
-24%
|
4
+11%
|
5
+33%
|
|
| Operating Income | |||||||||||||||||||||
| Operating Expenses |
(7)
|
(9)
|
(9)
|
(7)
|
(5)
|
(3)
|
(2)
|
(2)
|
(2)
|
(3)
|
(4)
|
(5)
|
(6)
|
(8)
|
(7)
|
(6)
|
(9)
|
(10)
|
(11)
|
(13)
|
|
| Selling, General & Administrative |
(2)
|
(2)
|
(3)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
|
| Research & Development |
0
|
(7)
|
(6)
|
(5)
|
(3)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(4)
|
(6)
|
(5)
|
(3)
|
(6)
|
(6)
|
(8)
|
(10)
|
|
| Depreciation & Amortization |
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
(5)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(5)
N/A
|
(6)
-26%
|
(7)
-13%
|
(6)
+14%
|
(4)
+30%
|
(3)
+41%
|
(2)
+26%
|
(2)
-8%
|
(2)
-8%
|
(2)
+14%
|
(2)
-23%
|
(3)
-32%
|
(4)
-18%
|
(5)
-45%
|
(6)
-20%
|
(5)
+28%
|
(5)
-1%
|
(6)
-37%
|
(7)
-8%
|
(8)
-22%
|
|
| Pre-Tax Income | |||||||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(5)
N/A
|
(6)
-27%
|
(7)
-13%
|
(6)
+14%
|
(4)
+29%
|
(3)
+41%
|
(2)
+26%
|
(2)
-9%
|
(2)
-9%
|
(2)
+17%
|
(2)
-24%
|
(3)
-35%
|
(4)
-18%
|
(5)
-44%
|
(6)
-19%
|
(4)
+29%
|
(5)
-1%
|
(6)
-37%
|
(7)
-6%
|
(8)
-21%
|
|
| Net Income | |||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(5)
|
(6)
|
(7)
|
(6)
|
(4)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(4)
|
(5)
|
(6)
|
(4)
|
(5)
|
(6)
|
(7)
|
(8)
|
|
| Net Income (Common) |
(5)
N/A
|
(6)
-27%
|
(7)
-13%
|
(6)
+14%
|
(4)
+29%
|
(3)
+41%
|
(2)
+26%
|
(2)
-9%
|
(2)
-9%
|
(2)
+17%
|
(2)
-24%
|
(3)
-35%
|
(4)
-18%
|
(5)
-44%
|
(6)
-19%
|
(4)
+29%
|
(5)
-1%
|
(6)
-37%
|
(7)
-6%
|
(8)
-21%
|
|
| EPS (Diluted) |
-0.25
N/A
|
-0.29
-16%
|
-0.3
-3%
|
-0.25
+17%
|
-0.17
+32%
|
-0.05
+71%
|
-0.04
+20%
|
-0.05
-25%
|
-0.04
+20%
|
-0.03
+25%
|
-0.02
+33%
|
-0.03
-50%
|
-0.02
+33%
|
-0.03
-50%
|
-0.03
N/A
|
-0.03
N/A
|
-0.02
+33%
|
-0.03
-50%
|
-0.02
+33%
|
-0.02
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
